GLUC (Glucose Health) Piotroski F-Score: 0 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GLUC Glucose Health Inc GLUC
38 GF Score
Price $0.39
View Full Analysis

What is Glucose Health Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Glucose Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Glucose Health's Piotroski F-Score or its related term are showing as below:

Glucose Health  (OTCPK:GLUC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Glucose Health Piotroski F-Score Related Terms


Glucose Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Glucose Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glucose Health Piotroski F-Score Chart

Glucose Health Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 4.00 5.00 4.00 4.00

Glucose Health Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Mar18 Jun18 Sep22 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 6.00 5.00 5.00 3.00
GLUC
38GF Score
Glucose Health Inc GLUC
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep17) TTM:
Net Income was -0.01200900000006 + 0.014932000000009 + -0.13173500000011 + -0.060614000000184 = $-0.19 Mil.
Cash Flow from Operations was -0.046788000000235 + 0.050213239996064 + -0.22993275429414 + -0.055927417318513 = $-0.28 Mil.
Revenue was 0.038421000000193 + 0.068739000000041 + 0.23493000000019 + 0.11481200000035 = $0.46 Mil.
Gross Profit was 0.014864000000075 + 0.031043000000019 + 0.06203200000005 + 0.087054000000264 = $0.19 Mil.
Average Total Assets from the begining of this year (Sep17)
to the end of this year (Sep23) was
(0.026353 + 0.086798 + 0.141797 + 0.778844 + 0.279737) / 5 = $0.2627058 Mil.
Total Assets at the begining of this year (Sep17) was $0.03 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $0.28 Mil.
Total Current Liabilities was $0.05 Mil.
Net Income was -0.12408 + -0.029009 + 0.049258 + 0.018769000000138 = $-0.09 Mil.

Revenue was 0.01519 + 0.015111 + 0.034046 + 0.023783000000175 = $0.09 Mil.
Gross Profit was 0.000386 + 0.0004730000000001 + 0.033774 + 0.022993000000169 = $0.06 Mil.
Average Total Assets from the begining of last year (Sep16)
to the end of last year (Sep17) was
(0.043962 + 0.033145 + 0.018865 + 0.027318 + 0.026353) / 5 = $0.0299286 Mil.
Total Assets at the begining of last year (Sep16) was $0.04 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $0.03 Mil.
Total Current Liabilities was $0.45 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Glucose Health's current Net Income (TTM) was -0.19. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Glucose Health's current Cash Flow from Operations (TTM) was -0.28. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep17)
=-0.18942600000034/0.026353
=-7.18802413

ROA (Last Year)=Net Income/Total Assets (Sep16)
=-0.085061999999862/0.043962
=-1.93489832

Glucose Health's return on assets of this year was -7.18802413. Glucose Health's return on assets of last year was -1.93489832. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Glucose Health's current Net Income (TTM) was -0.19. Glucose Health's current Cash Flow from Operations (TTM) was -0.28. ==> -0.28 <= -0.19 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep17 to Sep23
=0/0.2627058
=0

Gearing (Last Year: Sep17)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep16 to Sep17
=0/0.0299286
=0

Glucose Health's gearing of this year was 0. Glucose Health's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep23)=Total Current Assets/Total Current Liabilities
=0.276442/0.050021
=5.52651886

Current Ratio (Last Year: Sep17)=Total Current Assets/Total Current Liabilities
=0.026158/0.452585
=0.05779688

Glucose Health's current ratio of this year was 5.52651886. Glucose Health's current ratio of last year was 0.05779688. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Glucose Health's number of shares in issue this year was 17.012. Glucose Health's number of shares in issue last year was 4.148. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.19499300000041/0.45690200000077
=0.42677204

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.057626000000169/0.088130000000175
=0.65387496

Glucose Health's gross margin of this year was 0.42677204. Glucose Health's gross margin of last year was 0.65387496. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep17)
=0.45690200000077/0.026353
=17.33776041

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep16)
=0.088130000000175/0.043962
=2.00468587

Glucose Health's asset turnover of this year was 17.33776041. Glucose Health's asset turnover of last year was 2.00468587. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+1+1+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Glucose Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.


Glucose Health Business Description

Address 609 SW 8th Street, Suite 600, 6th Floor, Bentonville, AR, USA, 72712
Glucose Health Inc is an own-label distributor of nutritional beverages. Its niche is the formulation, manufacturing, marketing, and distribution of soluble fiber-infused nutritional beverages. The Company has identified two underserved consumer markets and has launched two brands to serve these markets, which are GlucoDown and FIBER UP. The Company currently has one single operating and reporting segment, which is the manufacturing and distribution of nutritional beverages. It generates all of its revenue from sales of nutritional beverages. The beverages are sold through the Company's website as well as through retailers.
38GF Score

Get the complete analysis for GLUC

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price